Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab (CURE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03306446
Recruitment Status : Active, not recruiting
First Posted : October 11, 2017
Last Update Posted : January 20, 2021
Sponsor:
Information provided by (Responsible Party):
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : March 2025